Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Chinese Omicron-specific mRNA COVID vaccine candidate to be trialed in UAE

FILE PHOTO: The words "OMICRON SARS-COV-2" are seen reflected in a drop from a syringe needle in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

With Friday's announcement, Abogen joins Pfizer/BioNTech and Moderna in trialing candidates modified specifically against Omicron, a highly transmissible variant with increased resistance to antibodies elicited by existing shots.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.